Distributed Bio has built its success, and the success of its clients and partners, on a synergy between three powerful technologies:

1) A computational platform for analysis and engineering of antibodies, TCRs and peptides

2) A discovery platform of advanced antibody libraries to recover high affinity, drug-worthy antibodies against any target

3) An epitope focusing technology to elicit immune responses against specific surfaces [contact us]